1 – 181 of 181
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Shrunken pore syndrome and mortality : a cohort study of patients with measured GFR and known comorbidities (
- Insufficient mixing of thawed serum samples leading to erroneous results–experience from a field study and use of a correction procedure (
- Secreted cystatins decrease proliferation and enhance apoptosis of human leukemic cells (
- 2019
- Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins (
- 2017
- Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors (
- Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome (
- Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells (
- 2015
- Calcium Regulates the Activity and Structural Stability of Tpr, a Bacterial Calpain-like Peptidase. (
- 2014
- Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C A ROLE FOR AMYLOID IN MALE INFERTILITY (
- 2013
- Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling (
- Stabilization, Characterization and Selective Removal of Cystatin C Amyloid Oligomers. (
- Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis (
- Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes. (
- 2012
- Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment (
- Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M (
- 2011
- Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis. (
- 2010
- Cystatin E/M suppresses legumain activity and invasion of human melanoma (
- Streptococcal inhibitor of complement-mediated lysis (SIC): an anti-inflammatory virulence determinant (
- Cystatins - Extra- and Intracellular Cysteine Protease Inhibitors: High-level Secretion and Uptake of Cystatin C in Human Neuroblastoma Cells. (
- Phenotype associated with mutation in the recently identified autosomal dominant retinitis pigmentosa KLHL7 gene. (
- 2009
- Mutations in a BTB-Kelch Protein, KLHL7, Cause Autosomal-Dominant Retinitis Pigmentosa (
- Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases (
- Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways. (
- Macrophage Responses to Interferon-gamma are Dependent on Cystatin C Levels. (
- Physiopathology of retinal degeneration in rd1 mouse model of retinitis pigmentosa : TGF-Β1, proteinases and oxidative stress mechanisms (
- 2008
- Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin (
- Internalization of cystatin C in human cell lines. (
- rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C. (
- The Human Protease Inhibitor Cystatin C Is an Activating Cofactor for the Streptococcal Cysteine Protease IdeS. (
- 2007
- Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties (
- Low glutathione peroxidase in rdl mouse retina increases oxidative stress and proteases (
- The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family (
- Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B. (
- The cysteine protease inhibitors cystatins inhibit herpes simplex virus type 1-induced apoptosis and virus yield in HEp-2 cells (
- Crystal Structure of the Parasite Protease Inhibitor Chagasin in Complex with a Host Target Cysteine Protease. (
- 2006
- rd1 Mouse Retina Shows Imbalance in Cellular Distribution and Levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and Sulfated Glycosaminoglycans. (
- Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation. (
- Cystatins in non-small cell lung cancer: Tissue levels, localization and relation to prognosis (
- Human cystatins - similarities, diversity and classification (
- Structural and protease inhibitory features of cystatins (
- 2005
- In search of selective inhibitors of cysteine protease, cathepsin K (
- Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse (
- Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile. (
- Clinical phenotype in a Swedish family with a mutation in the IMPDH1 gene. (
- Cystatin C uptake in the eye. (
- Juvenile X-linked retinoschisis with normal scotopic b-wave in the electroretinogram at an early stage of the disease. (
- Different cysteine proteinases involved in bone resorption and osteoclast formation (
- 3D domain-swapped human cystatin c with amyloidlike intermolecular beta-sheets (
- Inhibitory properties of cystatin F and its localization in U937 promonocyte cells (
- Novel azapeptide inhibitors of cathepsins B and K. Structural background to increased specificity for cathepsin B (
- 2004
- Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for igg cleavage due to exosite binding. (
- Engineered multidomain cysteine protease inhibitors yield resistance against western flower thrips (Franklinielia occidentalis) in greenhouse trials (
- Specific cysteine protease inhibitors act as deterrents of western flower thrips, Frankliniella occidentalis (Pergande), in transgenic potato (
- Glutathione S-transferase µ(GST) modifies activities of proteases and levels of cystatin C secreted by mouse retinal explants (
- Domain swapping in N-truncated human cystatin C (
- Osteoclastogenesis is decreased by cysteine proteinase inhibitors (
- Cystatin C is highly expressed in the human male reproductive system. (
- Cystatin C in the anterior segment of rat and mouse eyes. (
- Cysteine proteinases in osteoclast function and recruitment (
- 2003
- Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders (
- Cystatins. (
- Macular appearance by means of OCT and electrophysiology in members of two families with different mutations in RDS (the peripherin/RDS gene). (
- Cathepsin B in the rat eye. (
- Growth of the postnatal rat retina in vitro: Quantitative RT-PCR analyses of mRNA expression for photoreceptor proteins (
- 2002
- Physico-chemical properties of the N-terminally truncated L68Q cystatin C found in amyloid deposits of brain haemorrhage patients. (
- Regulated expression and intracellular localization of cystatin F in human U937 cells. (
- Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases (
- Structure-based design and synthesis of cathepsin K inhibitors (
- 2001
- Lysosomal protease pathways to apoptosis - Cleavage of Bid, not pro-caspases, is the most likely route (
- Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi (
- Peptidyl diazomethylketones as cysteine protease inhibitors structurally based upon the inhibitory centers of cystatins (
- Identification and localization of retinal cystatin C (
- Electrophysiologic findings in two young patients with Bothnia dystrophy and a mutation in the RLBP1 gene (
- Peptidyl aldehydes based on N-terminal binding fragments of cystatins as thioprotease inhibitors (
- Different clinical expressions in two families with Stargardt's macular dystrophy (STGD1) (
- Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping (
- 2000
- Functional effects of the inhibition of the cysteine protease activity of the major house dust mite allergen Der p 1 by a novel peptide-based inhibitor (
- Expression of an LDL receptor allele with two different mutations (E256K and I402T) (
- A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro (
- Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110 (
- 1999
- An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F) (
- Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site (
- Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C (
- Digenic inheritance of a ROM1 gene mutation with a peripherin/RDS or rhodopsin mutation in families with retinitis pigmentosa (
- Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene (
- Expression of a selenomethionine derivative and preliminary crystallographic studies of human cystatin C (
- 1998
- Mutations in the low-density lipoprotein receptor gene in Swedish familial hypercholesterolaemia patients: clinical expression and treatment response (
- Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor (
- Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C (
- Structural basis for different inhibitory specificities of human cystatins C and D (
- Intracellular accumulation of the amyloidogenic L68Q variant of cystatin C in NIH/3T3 cells (
- A Swedish family with a mutation in the peripherin/RDS gene (Arg-172-Trp) associated with a progressive retinal degeneration (
- Clinical expression of X-linked retinitis pigmentosa in a Swedish family with the RP2 genotype (
- Detection of alterations in all three exons of the peripherin/RDS gene in Swedish patients with retinitis pigmentosa using an efficient DGGE system (
- Amino acid substitutions in the N-terminal segment of cystatin C create selective inhibitors of lysosomal cysteine proteinases (
- Phenotypic expression of autosomal dominant retinitis pigmentosa in a Swedish family expressing a Phe-211-Leu variant of peripherin/RDS (
- Two-step mechanism of inhibition of cathepsin B by cystatin C, due to the inhibitor displacing the occluding loop of the enzyme (
- A 50-year perspective of a family with chromosome 14-linked Alzheimer’s disease (
- Phenotype in a Swedish family with X-linked retinitis pigmentosa caused by a novel splice defect in the RPGR gene (
- 1997
- Analysis of the RPGR gene in 11 pedigrees with the retinitis pigmentosa type 3 genotype: Paucity of mutations in the coding region, but splice defects in two families (
- Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines (
- Apolipoprotein E genotyping in Alzheimer’s disease and frontotemporal dementia (
- Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins (
- A mild phenotype of autosomal dominant retinitis pigmentosa is associated with the rhodopsin mutation Pro-267–Leu (
- Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis (
- Expression of cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue (
- Phenotypes in three Swedish families with X-linked retinitis pigmentosa caused by different mutations in the RPGR gene (
- Affinity purification and elimination of methionine oxidation in recombinant human cystatin C (
- NMR structural studies of human cystatin C dimers and monomers (
- Autosomal dominant retinitis pigmentosa with a rhodopsin mutation (Arg-135–Trp): Disease phenotype in a Swedish family (
- 1996
- Folding related dimerization of human cystatin C (
- Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution (
- Lack of relationship between insertion/deletion polymorphism in the angiotensin converting enzyme gene and severe retinopathy in insulin-dependent diabetes mellitus (
- The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases (
- Molecular basis for amyloidosis related to hereditary brain hemorrhage (
- 1995
- Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases (
- Phenotype variation within a choroideremia family lacking the entire CHM gene (
- Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases (
- Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase (
- Antigenicity of cystatin-binding proteins from parasitic protozoan. Detection by a proteinase inhibitor based capture immunoassay (PINC-ELISA) (
- Structural organization, expression and chromosomal mapping of the mouse cystatin C gene (Cst3) (
- An efficient screening procedure detecting six novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia (
- 1994
- Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B (
- Secretion of cathepsin B and tumor invasion (
- Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases (
- Increased body temperature accelerates aggregation of the (Leu-68–>Gln) mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy (
- Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase (
- Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes (
- Cystatins (
- 1993
- Human cystatin D: cDNA cloning, characterization of the E. coli expressed inhibitor, and identification of the native protein in saliva (
- Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2 (
- An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a Sst II polymorphism (
- Cystatins - Protein inhibitors of papain-like cysteine proteinases (
- Importance of the evolutionarily conserved glycine residue in the N-terminal region of cystatin C (Gly-11) for cysteine endopeptidase inhibition (
- Localization of the human cystatin D gene (CST5) to chromosome 20p11.21 by in situ hybridization (
- A sequence variation in the human cystatin D gene resulting in an amino acid (Cys/Arg) polymorphism at the protein level (
- 1992
- Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: Influence of the peptidyl chain length (
- A novel mutation in the β-protein coding region of the amyloid β-protein precursor (APP) gene (
- PCR assay for a polymorphic Dde I site in the promoter region of the human cystatin C gene (CST3) (
- Demonstration of sequence variations in the promoter region of the human cystatin C gene (
- Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin (
- A six generation family with autosomal dominant retinitis pigmentosa and a rhodopsin gene mutation (arginine-135–leucine) (
- Hereditary cystatin C amyloid angiopathy: Identification of the disease causing mutation and specific diagnosis by polymerase chain reaction based analysis (
- Cystatin C and cathepsin B in human colon carcinoma: Expression in cell lines and matrix degradation (
- 1991
- Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor (
- Human monoclonal antibodies with different fine-specificity for digoxin derivatives: Cloning of heavy and light chain variable region sequences (
- Sst II polymorphic sites in the promoter region of the human cystatin C gene (
- Determination of allotypes G1m(f) and G1m(z) at the genomic level by subclass specific amplification of DNA and use of allele specific probes (
- Human cystatin C: Role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase (
- Human sputum cathepsin B degrades proteoglycan, is inhibited by a2-macroglobulin and modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C (
- Regulation of cystatin C activity by serine proteinases (
- 1990
- Three RFLP's at the 3' end of the cystatin C gene, the disease gene in hereditary cystatin C amyloid angiopathy (HCCAA) in Iceland (
- Interactions of papaya proteinase IV with inhibitors (
- Cystatin C mutation causing amyloid angiopathy and brain hemorrhage (
- Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation (
- Structure and expression of the human cystatin C gene (
- Assignment of allotypes G1m(a+) and G1m(a-) at the genomic level by polymerase chain reaction analysis (
- The aminoterminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated. Direct sequence analysis from agarose gel electropherograms (
- Synthesis of cysteine proteinase inhibitors structurally based on the proteinase interacting N-terminal region of human cystatin C (
- Human cystatin C. An overview of a cysteine proteinase inhibitor in health and disease (
- Secreted active forms of cathepsin B (
- 1989
- Bacterial growth inhibited by a synthetic inhibitor based upon the structure of a human proteinase inhibitor (
- High-level expression of active human cystatin C in Escherichia coli (
- Study of restriction fragment length polymorphism in the cystatin C gene of elderly patients with dementia and aged Down's syndrome patients (
- The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20 (
- Polymemse chain reaction using mixed primers. Cloning of human monoclonal antibody variable region genes from single hybridoma cells (
- Mutation in the cystatin C gene causes hereditary brain hemorrhage (
- Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction (
- An efficient E. coli expression system for human cystatin C: Production and characterization of the native and N-terminally Ala-Met-Glu-Ala-Glu-extended inhibitor (
- 1988
- Mutation in cystatin C gene causes hereditary brain haemorrhage (
- Efficient production of native, biologically active human cystatin C by Escherichia coli (
- Human cysteine proteinase inhibitors. Isolation, physiological importance, inhibitory mechanism, gene structure and relation to hereditary cerebral hemorrhage (
- Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen (
- Studies on the cystatin C gene in patients with hereditary cystatin C amyloid angiopathy (HCCAA) with cerebral haemorrhage (
- An isolate of families with hereditary cystatin C amyloid angiopathy and cerebral haemorrhage in the south of Iceland (
- 1987
- Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin (
- Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C (
- 1986
- Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids (
- Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. (
- The biochemistry of the action of chymopapain in relief of sciatica (
- Cystatin-like domains of LMW-kininogen, and speculations on the evolution of cystatins (